Questions? Call 800-624-6242 About | Ordering | New Menu | Items in cart [0] SEARCH

PAPERBACK price:$31.00 add to cart Rights & Permissions Free PDF Access Sign in to download PDF book and chapters Free Resources PDF Report Brief PDF SUMMARY Display this book on your site! Related Titles Adverse Effects of Vaccines: Evidence and Causality Adverse Events Associated with Childhood Vaccines:Evidence Bearing on Casuality Other Related Titles Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (2002) Board on Health Promotion and Disease Prevention (HPDP) Institute of Medicine (IOM) Citation Manager Export the bibliographic data for this book in your chosen format Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Citation Manager . "Appendix B: Public Meeting Agenda." Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders. Washington, DC: The National Academies Press, 2002. Please select a format: Page 100   E-mail Share on facebook Facebook Share on delicious Delicious Share on stumbleupon Stumble Share on twitter Twitter More Sharing ServicesMore The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. Appendix B Public Meeting Agenda March 11, 2002 Immunization Safety Review Committee Hepatitis B Vaccine and Neurological Disorders Foundry Building, Room 2004 Washington, DC 8:30–8:45 am Welcome and Introduction Marie McCormick, MD, ScD Committee Chair 8:45–9:00 am Clinical Description and Diagnosis of Multiple Sclerosis Emmanuelle Waubant, MD University of California, San Francisco Multiple Sclerosis Center (co-author of commissioned paper posted on IOM website) 9:00–9:30 am Pharmacovigilance and Case-Control Study of Hepatitis B Vaccine and Multiple Sclerosis Bernard Begaud, MD, PhD (Presented via conference call) Annie Fourrier, PharmD, MPH (Presented via conference call) Universite Victor Segalen Bordeaux, France 9:30–10:15 am Risk of Multiple Sclerosis Relapse After Immunization: European Database for Multiple Sclerosis Page 100 Front Matter (R1-R14) Executive Summary (1-16) Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders (17-90) Appendix A: Committee Conclusions and Recommendations from Previous Reports (91-99) Appendix B: Public Meeting Agenda (100-102) Appendix C: Chronology of Important Events Regarding Vaccine Safety (103-106)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 100
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders Appendix B Public Meeting Agenda March 11, 2002 Immunization Safety Review Committee Hepatitis B Vaccine and Neurological Disorders Foundry Building, Room 2004 Washington, DC 8:30–8:45 am Welcome and Introduction Marie McCormick, MD, ScD Committee Chair 8:45–9:00 am Clinical Description and Diagnosis of Multiple Sclerosis Emmanuelle Waubant, MD University of California, San Francisco Multiple Sclerosis Center (co-author of commissioned paper posted on IOM website) 9:00–9:30 am Pharmacovigilance and Case-Control Study of Hepatitis B Vaccine and Multiple Sclerosis Bernard Begaud, MD, PhD (Presented via conference call) Annie Fourrier, PharmD, MPH (Presented via conference call) Universite Victor Segalen Bordeaux, France 9:30–10:15 am Risk of Multiple Sclerosis Relapse After Immunization: European Database for Multiple Sclerosis

OCR for page 101
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders   Samy Suissa, PhD McGill University 10:15–10:30 am Break 10:30–11:15 am Risk of Multiple Sclerosis After Hepatitis B Immunization: The Nurses’ Health Study Alberto Ascherio, MD, DrPH Harvard University 11:15 am–12:00 pm Risk of Demyelinating Disease After Hepatitis B Vaccination: The Vaccine Safety Datalink Frank DeStefano, MD, MPH Centers for Disease Control and Prevention 12:00 pm–1:00 pm Lunch 1:00–1:45 pm Possible Mechanisms for Hepatitis B Vaccine-Induced Multiple Sclerosis and Other Demyelinating Diseases Emmanuelle Waubant, MD University of California, San Francisco Multiple Sclerosis Center (co-author of commissioned paper posted on IOM website) 1:45–2:30 pm Recommendations for Newborn and Infant Hepatitis B Vaccination Historical Perspective Neal Halsey, MD Johns Hopkins University Recent Analyses of Hepatitis B Viral Infections in Children Eric Mast, MD National Center for Infectious Diseases Centers for Disease Control and Prevention

OCR for page 102
Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders 2:30–3:15 pm Update on Communications Activities, National Immunization Program, Centers for Disease Control and Prevention Glen Nowak, PhD Centers for Disease Control and Prevention 3:15–4:00 pm Public Comment Session and Discussion 4:00 pm Adjourn

Representative terms from entire chapter:

immunization safety